Cite
HARVARD Citation
Calderoni, S. et al. (2018). The role of neoadjuvant chemoterapy in choosing the type of surgery in breast cancer HER2+ and triple negative. European journal of surgical oncology. 44 (4), pp. 554-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Calderoni, S. et al. (2018). The role of neoadjuvant chemoterapy in choosing the type of surgery in breast cancer HER2+ and triple negative. European journal of surgical oncology. 44 (4), pp. 554-. [Online].